Merck Offers $9.2bn To Buy Cidara And Phase III Antiviral Flu Preventative

 
• By Joseph Haas
  
Elderly
Merck will pay $9.2bn to acquire Cidara and its antiviral flu preventative • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business